Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
KRYS
#874
Krystal Biotech, Inc. Common Stock
275.640
0
+1.85%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+1.85%
Changement Mensuel
-0.92%
Evolution sur 6 mois
+47.30%
Changement Annuel
+47.30%
Clôture Précédente
270.630
0
Open
275.640
0
Bid
Ask
Low
275.640
0
High
275.640
0
Volume
67
Marchés
Actions des Marchés US
Soins de Santé
KRYS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
28.76 M
28.81 M
28.9 M
28.94 M
29 M
29.23 M
—
Valuation ratios
Enterprise value
4.86 B
4.17 B
4.9 B
3.62 B
4.73 B
6.71 B
19.96 B
Price to earnings ratio
87.51
52.22
43.24
27.88
26.43
36.04
133.59
Price to sales ratio
22.01
16.04
16.06
11.39
14.1
18.98
60.54
Price to cash flow ratio
68.81
37.75
38.72
20.94
29.86
36.76
126.28
Price to book ratio
1.6
4.92
1.46
1.06
1.28
6.05
9.86
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.03
0.03
0.06
0.04
0.17
Return on equity %
0.03
0.05
0.04
0.04
0.07
0.04
0.19
Return on invested capital %
22.21
25.02
26.31
28.8
35.93
35.83
126.87
Gross margin %
100
100
100
100
100
100
400
Operating margin %
26.76
30.69
41.02
40.93
42.3
41.49
165.75
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
32.42
49.9
40.52
39.91
81.15
47.99
209.57
Liquidity ratios
Quick ratio
7.76
7.02
9.27
9.33
9.73
9.56
37.88
Current ratio
7.97
7.28
9.65
9.68
10.14
9.95
39.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.09
0.09
0.08
0.09
0.08
0.08
0.34
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1.97
1.78
1.04
1.77
1.33
2.59
6.73
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
19.67
20.09
20.65
22.93
24.51
27.64
95.72
Net current asset value per share
23.85
24.95
25.67
28.28
31.03
34.21
119.19
Tangible book value per share
29.62
31.82
32.96
34.98
38.14
40.72
146.81
Working capital per share
20.86
21.52
23.01
25.36
27.97
30.77
107.11
Book value per share
29.62
31.82
32.96
34.98
38.14
40.72
146.81
Nouvelles
Un directeur de Krystal Biotech vend des actions pour 10,1 millions de dollars
Krystal Biotech director Janney sells shares worth $10.1 million
Le directeur de Krystal Biotech (KRYS) Rossi vend des actions pour 4,95 millions $
Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million
AI Play SPX Leads 17 Top Performers Onto Best Stock Screens Like IBD 50, Stock Spotlight, More
Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark
Dow Jones Futures Fall After Market Reverses Higher; Meta Deal Lifts Nvidia, Hits AI Rivals
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript
L’action Krystal Biotech atteint un sommet historique à 296,78 USD
Krystal Biotech stock reaches all-time high at 296.78 USD
Krystal Biotech Q4 2025 slides: VYJUVEK drives revenue growth, pipeline advances
Krystal Biotech shares fall over 2% despite Q4 earnings, revenue beat